CRL-1605

N/A

Report date: 2023/05/25 14:07:48

Base Information

Drug NameCRL-1605

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionP-glycoprotein 1 inhibitors

TargetsP-glycoprotein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCytrx Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCytrx Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A

Related LinksN/A